KU 2019 Post San Antonio Breast Cancer Review

 

KU 2019 Post San Antonio Breast Cancer Review
T

SABCS 2019 Updates on Breast Cancer Chemoprevention: Anastrozole Significantly Reduces Incidence by 49% In Postmenopausal Women

By KU 2019 Post San Antonio Breast Cancer Review FEATURING Terry Mamounas
By KU 2019 Post San Antonio Breast Cancer Review FEATURING Terry Mamounas
25 views
March 12, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

11:11
Lilly Medical Affairs

Supporting Patients With Breast Cancer in the Clinic: Setting the Pa…

Feat. S. Dawood

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy
Videos
17:37

SABCS 2019 Highlights on Metastatic HER2+ Breast Cancer: Outcomes of…

KU 2019 Post San Antonio Breast Cancer Review

W. Gradishar

199 views
11:53

SABCS 2019 Highlights on Metastatic HER2+ Breast Cancer Management: …

KU 2019 Post San Antonio Breast Cancer Review

W. Gradishar

1.3K views
10:29

SABCS 2019 Highlights on Adjuvant Therapy Options for HER2+ Breast C…

KU 2019 Post San Antonio Breast Cancer Review

W. Gradishar

1.3K views
18:55

SABCS 2019 Highlights on Early Stage TNBC: 5-FU Has a Benefit, Neoad…

KU 2019 Post San Antonio Breast Cancer Review

V. Kaklamani

345 views
06:40

SABCS 2019 Highlights on IO in mTNB: IMpassion130 Suggest PD-L1+ Pts…

KU 2019 Post San Antonio Breast Cancer Review

V. Kaklamani

197 views
09:08

SABCS 2019 Updates on Breast Cancer Chemoprevention: Anastrozole Sig…

KU 2019 Post San Antonio Breast Cancer Review

T. Mamounas

25 views
23:29

SABCS 2019 Updates on Early Stage HR+: Oral Formulation S-1 + Adjuva…

KU 2019 Post San Antonio Breast Cancer Review

T. Mamounas

20 views
07:01

SABCS 2019 Updates on Metastatic HR+ BC: PEARL Suggests Treatment Wi…

KU 2019 Post San Antonio Breast Cancer Review

T. Mamounas

240 views
11:46

52 y/o With HER2+/HR- De-novo Metastatic BC / 52 y/o With T2N0 HR+/H…

KU 2019 Post San Antonio Breast Cancer Review

A. Kurian, Q. Khan, P. Sharma, V. Kaklamani, T. Mamounas, W. Gradishar

18 views
11:23

46 y/o F With Grade 2, 2.5 cm, NO ER+ Left BC / 40 y/o Premenopausal…

KU 2019 Post San Antonio Breast Cancer Review

A. Kurian, Q. Khan, P. Sharma, V. Kaklamani, T. Mamounas, W. Gradishar

26 views
08:39

55 y/o Diagnosed With T3NO TNBC / 42 y/o With cT2N+ Grade IlTNBC, Re…

KU 2019 Post San Antonio Breast Cancer Review

A. Kurian, Q. Khan, P. Sharma, V. Kaklamani, T. Mamounas, W. Gradishar

13 views